YourChoice Therapeutics, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2018-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.yourchoicetx.com
Clinical Trials
2
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (100.0%)Open Label, Repeat Dose Study Evaluating YCT-529 in Healthy Males
- First Posted Date
- 2024-08-07
- Last Posted Date
- 2025-04-13
- Lead Sponsor
- YourChoice Therapeutics, Inc.
- Target Recruit Count
- 66
- Registration Number
- NCT06542237
- Locations
- 🇳🇿
New Zealand Clinical Research (NZCR), Grafton, Auckland, New Zealand
First in Human Study Evaluating Single Ascending Oral Doses of YCT-529 in Healthy Males
- First Posted Date
- 2023-10-23
- Last Posted Date
- 2024-10-02
- Lead Sponsor
- YourChoice Therapeutics, Inc.
- Target Recruit Count
- 16
- Registration Number
- NCT06094283
- Locations
- 🇬🇧
Quotient Sciences, Nottingham, East Midlands, United Kingdom
News
No news found